Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access


Vet World. 2010; 3(6): 272-274

Efficacy of various antiprotozoal drugs on bovine babesiosis, anaplasmosis and thileriosis

Nasreen Akhter, Chamon Lal, Javaid Ali Gadahi, Khuda Bux Mirbahar, and Mohammad Ismail Memon.

Cited by (1)

The present study was conducted to check out the efficacy of various antiprotozoal drugs on bovine babesiosis, anaplasmosis and theleriosis. 38 buffaloes naturaly infected with anaplasma, babesia and theileria were selected and divided into four groups. Group A (10), B (10), C (08) and D (10) infected with anaplasmosis, babesiosis, theileriosis, and Infected Control (anaplasmosis (4), anaplasmosis + babesiosis (1 each), babesiosis (2) and theileriosis (2) respectively. Group A was further subdivided into A-I (5 animals with pure Anaplasmosis) and A-II (5 animals with mixed infection of Anaplasmosis and Babesiosis). Group-A was treated with a single dose of imidocarb dipropionate (3 mg / kg body weight). In Group A-I one animal recovered completely, 02 moderately while remaining 02 animals did not respond. The later 02 animals recovered completely after additional 02 doses of 4 mg/kg body weight. In case of group A-II complete recovery was recorded in one animal, moderate recovery in three animals while one animal showed no responsel. Group B was treated with Diminazene acceturate (3. 5 mg / kg body weight) administered as a single dose. 6 animals recovered completely, 02 moderately while 02 animals showed no response. Group C was treated with a single dose of Buparvaqune (2.5 mg / kg body weight), complete recovery was recorded in 4 animals, 2 animals showed no response, while 2 animals with severe infection died after 24 hrs.

Key words: Babesiosis, anaplasmosis, theileriosis, drug efficacy, buffalo

Share this Article

Journal of Interdisciplinary Histopathology


ScopeMed Home
Follow ScopeMed on Twitter
Article Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons